Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-Human Study of a Novel 3rd Molar Tooth Bud Ablation Procedure

NCT05374993 is registered in ClinicalTrials.gov with TriAgenics Inc as lead sponsor.

NCT NCT05374993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05374993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-Human Study of a Novel 3rd Molar Tooth Bud Ablation Procedure
Lead sponsor
TriAgenics Inc
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
June 30, 2027
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

molar, third